SP1 and colorectal carcinoma: Butyrate could diminish the expression of neuropilin 1 by suppressing the transactivation of Specificity protein 1 (Sp1) to inhibit the angiogenesis, metastasis, and survival of CRC cells, and butyrate could trigger the CRC cells apoptosis by activating the signalling of Wnt [51].